MCMarta Rodrigues de Carvalho

Marta Rodrigues de Carvalho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marta Rodrigues de Carvalho has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic Accuracy of Peroneal Nerve Chronaxie for Bedside Screening of Critical Illness Polyneuropathy and/or Myopathy in Mechanically Ventilated Patients: a Prospective, Cross-Sectional Study

    by José Roberto de Deus Macedo, Emerson Fachin-Martins, Marta de Carvalho, Rubens Fernandez, Paulo Silva

    Background/Objective: Critical illness polyneuropathy and/or myopathy (CIP/CIM) is a highly prevalent risk factor for weaning failure in mechanically ventilated patients in intensive care unit (ICU). Gold standard for CIP/CIM diagnosis, conventional electrodiagnostic tests may face practical constraints in uncooperative patients. Chronaxie analysis has been proposed as a feasible alternative for early CIP/CIM screening. However, its diagnostic accuracy remains understudied in the ICU scenario. This study aimed to investigate the Stimulus Electrodiagnosis Test (SET)’s optimal peroneal nerve chronaxie cutoff point and corresponding diagnostic metrics, as a bedside CIP/CIM screening tool for uncooperative ICU patients on mechanical ventilation (MV).Methods: A prospective, cross-sectional study was conducted with adult mechanically ventilated ICU participants. A single bilateral assessment per participant included the peroneal simplified electrophysiological test (PENT) as the reference and SET (index test). A receiver operating characteristic (ROC) curve was constructed to determine the optimal chronaxie cutoff point and the corresponding SET's diagnostic metrics were determined: accuracy, sensitivity, specificity, predictive values, and likelihood ratios.Results: From sixty participants, 101 assessments were performed. SET's AUC was 0.7 (95% CI: 0.59–0.81, p=0.001), with an optimal chronaxie cutoff of 1.8 ms. From this threshold, SET showed 71% (62-75%) accuracy, 89% (79-85%) sensitivity, and 42% (28-58%) specificity for CIP/CIM screening.Conclusions: SET, with a peroneal nerve chronaxie threshold adjusted for ICU setting, presents as a promising adjunct for early bedside CIP/CIM screening in mechanically ventilated ICU patients. Multicenter studies are warranted to validate these findings and integrate SET into ICU clinical practice.

  • Open Access

    Diagnostic Performance of the Strength‐Duration Test for Bedside Screening of Critical Illness Polyneuropathy and/or Myopathy: A Prospective, Cross‐Sectional Study

    by José Roberto de Deus Macedo, Emerson Fachin‐Martins, Marilia Mendes Rodrigues, Marta Rodrigues de Carvalho, Rubens Nelson Morato Fernandez, Paulo Eugênio Silva

    Introduction/Aims: Critical illness polyneuropathy and/or myopathy (CIP/CIM) is a major cause of weakness in the intensive care unit (ICU). The availability of conventional electrodiagnostic testing may be limited. Alternative electrophysiologic methods, including the strength‐duration test (SDT) and the stimulus electrodiagnosis test (SET), have been proposed as bedside screening adjuncts. This study aimed to evaluate the SDT's diagnostic metrics for CIP/CIM screening and to compare with the SET's performance. Methods: This prospective, cross‐sectional study included adult, mechanically ventilated ICU patients. Single assessment per patient comprised the peroneal simplified electrophysiological test (PENT), SDT, and SET. Using PENT as the reference test, we calculated the accuracy, sensitivity, specificity, predictive values, and likelihood ratios of SDT. Receiver operating characteristic curves were constructed to assess the discriminative performance and optimal cutoff. Results: Sixty participants were enrolled, yielding 101 assessments, including bilateral evaluations when feasible. The SDT demonstrated an area under the curve (AUC) of 0.8 (95% CI: 0.7–0.8, p < 0.001), with an optimal cutoff of 600 mC. At this cutoff, SDT showed a sensitivity of 73% (95% CI: 61–82), specificity of 68% (95% CI: 53–81), accuracy of 71% (95% CI: 62–79), and positive likelihood ratio of 2.3 (95% CI: 1.41–3.78) for screening probable CIP/CIM. The SET yielded an AUC of 0.7 (95% CI: 0.6–0.8, p = 0.001). Discussion: The SDT showed potential as a bedside screening adjunct for CIP/CIM in the ICU setting. Further multicenter studies are required to validate these findings and to define the role of SDT in clinical practice.

  • Open Access

    Multimodal Intraoperative Neurophysiological Monitoring in TUBB4A ‐Related Hypomyelinating Leukodystrophy During Scoliosis Correction: A Case Report

    by Marta Rodrigues de Carvalho, Eduardo Henrique Chiovato Abdala, Carlos Fernando Pereira da Silva Herrero, Narcélio Mendes Ferreira Filho, Vitor Marques Caldas

    Intraoperative neurophysiological monitoring (IONM) is essential in spinal deformity surgery; however, it may be limited in patients with hypomyelinating leukodystrophy and impaired long‐tract conduction. Data on the neurophysiological features of leukodystrophies are scarce. Therefore, we report a case of a 15‐year‐old patient with hypomyelinating leukodystrophy who underwent surgical correction of severe scoliosis (Cobb angle 76°), with a surgical duration of 360 min. During the procedure, transcranial motor evoked potentials (MEPs) and somatosensory‐evoked potentials (SSEPs) could not be obtained despite maximal stimulation parameters, a finding attributed to severe central hypomyelination. In contrast, the bulbocavernosus reflex (BCR) remained reproducible and stable throughout, documenting the integrity of the segmental sacral reflex circuit (S2–S4) and its peripheral innervation. Surveillance was complemented by free‐running electromyography (EMG) and surgeon feedback. The patient had no postoperative neurological deficit, with maintained motor and sphincter function. In patients with hypomyelinating leukodystrophy, the absence of MEPs and SSEPs may not indicate surgical injury but rather reflect impaired long‐tract conduction. The preserved BCR offers a valuable segmental monitoring modality, and a concomitant multimodal strategy—BCR, free‐running EMG, and surgeon feedback—should be considered when evoked potentials are unobtainable. This is the first report detailing intraoperative MEPs and SSEPs findings in this rare population, underscoring the need for adapted IONM protocols in patients with rare and complex neurological comorbidities.

  • Open Access

    Rett syndrome due to mutation in the MECP2 gene and electroencephalographic findings

    by Marta Rodrigues de Carvalho, Thiago Toscano Cavalcante, Pedro Sudbrack Oliveira, Pedro Vicente Ferreira Naves, Paulo Emidio Lobão Cunha

    A 6-year-old girl with MECP2-positive Rett syndrome presented for investigation of seizures. The electroencephalogram (EEG) showed markedly disorganized cerebral activity, epileptiform paroxysms and a quasiperiodic pattern, followed by attenuation after paroxysmal activity ([Figures 1] and [2]). In MECP2-positive patients, there is a progression of EEG findings in stages. First, seizures are not a prominent feature, and the EEG may be normal. Second, focal spikes may be observed, especially in the centrotemporal regions. Third, there is an accentuation of epileptiform activity, abnormalities during sleep, and the presence of bilaterally synchronous discharges of pseudoperiodic delta activity and generalized rhythmic spike discharges. Fourth, there are theta waves in the central and frontal regions, multifocal epileptiform activity in the waking state, and generalized slow spike and wave activity during sleep.[1] [2] Hélio A. G. Teive Luciano de Paola MRC: conceptualization and design of the work, data acquisition, analysis, and interpretation, and writing of the manuscript; TTC: data acquisition and writing of the manuscript; PSO, PVFC: analysis and interpretation of data, review of the manuscript; PELC: analysis and interpretation of data, and writing and review of the manuscript. All authors have approved the final version of the manuscript and agreed to be responsible for all aspects of the work. Received: 03 February 2024 Accepted: 06 April 2024 Article published online: 29 July 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil


  • Open Access

    Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy following mRNA SARS-CoV-2 Vaccination

    by Marta Rodrigues de Carvalho, Myrian Mathildes Sá de Deus Rocha, Vinícius Alves Bezerra, Maciel Eduardo de Pontes, Maria Cristina del Negro, Julio Salgado Antunes, Vinícius Viana Abreu Montanaro, Rubens Nelson Morato Fernandez

    The new coronavirus (COVID-19) pandemic has resulted in the unprecedented production of vaccines. In this context, the possible adverse effects remain to be identified and reported. In this article, we report the case of a young female patient who developed anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMG-CoA) immune-mediated necrotizing myositis (IMNM) after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine. The diagnosis of probable post-vaccination IMNM was made due to the absence of other factors that may have led to the development of autoantibodies (medicines; e.g., statins, drugs) and the temporal relationship between exposure and event. This case report is the first to suggest that a COVID-19 vaccine may trigger anti-HMG-CoA reductase necrotizing myopathy.


  • Open Access

    Nutritional assessment of patients with aneurysmal subarachnoid hemorrhage using the modified “Nutrition Risk in the Critically ill" score, and its association with outcomes

    by Marta Rodrigues de Carvalho, Beatriz Schmidt Dal Berto, Amelia Maia Rodrigues, Lorena Ohrana Braz Prudente, Edmilson Leal Bastos de Moura

    Revista oficial de la Sociedad Española de Nutrición Parenteral y de la Sociedad Española de Nutrición. Está dedicada al estudio y divulgación de temas relacionados con la nutrición.


  • Open Access

    COVID-19 as the trigger for respiratory failure in neuromuscular diseases

    by Marta Rodrigues de Carvalho, Beatriz Schmidt Dal Berto, Priscila Leite Santos, Guilherme Coelho de Azevedo, Rubens Nelson Morato Fernandez, Talyta Grippe

    We read with great interest the article by Studart-Neto et al.1, which presented the importance of recognizing neurological conditions that can worsen the prognosis of SARS-CoV-2 infection. We acknowledge the notable work demonstrating that knowledge in neurology is relevant for better treatment and follow-up of the disease.


  • Open Access

    Prognosis of the outcome of severe diabetic foot ulcers with multidisciplinary care

    by Luz Marina Alfonso Dutra, Manuela Costa Melo, Mirian Conceição Moura, Lílian Assumpção Paes Leme, Marta Rodrigues De Carvalho, Andre Neves Mascarenhas, Maria Rita Carvalho Garbi Novaes

    Background: Approximately 2–4% of individuals worldwide with diabetes mellitus have foot ulcers. This study aims to assess the factors affecting the outcomes of severe foot ulcers in diabetic individuals. Methods: An analytical prospective cohort study was conducted from March 1st, 2015, to March 1st, 2017. A total of 34 individuals was selected. The study included patients with foot ulcers below the ankle who were at risk of amputation. All tests used a 7%. Body mass index and osteomyelitis were the two significant variables in logistic regression. Conclusions: In this study, osteomyelitis was the main complication related to the risk of amputation, and elevated body mass index and osteomyelitis were the significant factors that induced a slower healing time.


  • Open Access

    Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries

    by Ricardo Eccard da Silva, Angélica Amorim Amato, Débora Dornelas Belchior Costa Andrade, Alessandra Vanessa Leite e Silva, Marta Rodrigues de Carvalho, Maria Rita Carvalho Garbi Novaes

    Cancer incidence has increased significantly in low- and middle-income countries. The priorities of international health research are not always aligned with the global burden of cancer. This study aims to analyze global tendencies in clinical trials in oncology and discuss research priorities and resource allocation in the investigation of new drugs for cancers that significantly affect the least developed countries. This was a retrospective and analytical study that included data collected from the World Health Organization’s International Clinical Trials Registry Platform (ICTRP) in 2014. According to our results, there was a tendency for clinical trials involving breast and lung cancer to be conducted in countries with a lower level of economic development. On the other hand, cervical, stomach, and liver cancer, despite the significant burden that these place on middle- and low-income countries, were studied little among the countries selected. In conclusion, the organizations that most fund research to develop new drugs for cancer treatment continue to show little interest in prioritizing resources to fund research for certain types of cancer such as those of the cervix, stomach, and liver, which have a significant impact in low- and middle-income countries.


  • The patient’s safety and access to experimental drugs after the termination of clinical trials: regulations and trends

    by Ricardo Eccard da Silva, Angélica Amorim Amato, Thiago Do Rego Sousa, Marta Rodrigues de Carvalho, Maria Rita Carvalho Garbi Novaes

    Participants’ rights and safety must be guaranteed not only while a clinical trial is being conducted but also when a clinical trial finishes. The criteria for post-trial access to experimental drugs, however, are unclear in various countries. The objectives of this study were (i) to ascertain if there were regulations or guidelines related to patients’ access to drugs after the end of clinical trials in the countries selected in the study and (ii) to analyze trends in post-trial access in countries classified by their level of economic development.